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Nature of the uricosuric effect of tienilic acid, a new diuretic.
Tienilic acid (2, 3-dichloro-4-[2.thienyl carbonyl] phenoxyacetic
acid) is a new diuretic with uricosuric properties in man. Experi-
ments were designed in the mongrel dog, Dalmatian coachhound,
rat, guinea pig, rabbit, and chicken to clarify the nature of tienilic
acid-induced uricosuria. It was demonstrated that tienilic acid is
the most potent uricosuric agent yet reported in the mongrel dog.
Following the iv. administration of tienilic acid (50 mg/kg of body
wt), the ratio of urate clearance over exogenous creatinine clear-
ance (Cur/C) rose from 0.41 to 1.0 within 10 mi this effect
persisting for another 20 mm and declining progressively thereafter
to a value of 0.70 at 100 mm. The effect was the same in urate-
loaded and unloaded animals. No uricosuric effect was noted in the
Dalmatian coachhound. In this animal, mean Cur/Ccr fell from
1.15 to 1.00 following tienilic acid. Pyrazinoic acid given iv, to
urate-loaded mongrel dogs before or after tienilic acid did not
influence the uricosuric response to the drug. Stop-flow studies in
dogs revealed that tienilic acid blocks net urate reabsorption in the
proximal segment of the nephron. It was also demonstrated that
tienilic acid depresses para-aminohippurate (PAH) transport
markedly both at high (20 mg/l00 ml) and low (I mg/l00 ml)
concentrations of plasma PAH. Thus, PAH clearance cannot be
used to measure renal plasma flow following tienilic acid unless the
renal extraction of PAH is estimated. We have shown that tienilic
acid is also uricosuric in the rat, albeit to a lesser degree than in
the dog. In spite of a considerable natriuretic effect, tienilic acid
had a significant antiuricosuric action in urate-secreting animals
like the guinea pig, rabbit, and chicken. The present studies dem-
onstrate that tienilic acid may affect markedly either the reabsorp-
tive or the secretory flux of urate. This action takes place in the
proximal tubule and appears to be independent of the natriuretic
activity of the drug. It is probable that the drug competes for the
common (PAH) organic acid pathway and that the common car-
rier has far more affinity for tienilic acid than for PAH.
Nature de I'effet uricosurique de l'acide tiénilique, un nouveau
diurétique. L'acide tienilique [2,3-dichloro-4(2-thienyl carbonyl)
acide phenoxyacetique] est un nouveau diurétique qui posséde des
propriétés uricosuriques chez !'homme. La nature de I'uricosurie
induite par l'acide tiénilique a óté étudiée au moyen d'expériences
réalisées chez le chien batard, Ic chien dalmatien, le rat, Ic cobaye, le
lapin et le poulet. II a été démontré que l'acide tiénilique est Ic plus
puissant uricosurique connu a l'heure actuelle chez le chien batard.
Après l'administration d'acide tiénilique (50 mg/kg) par voie in-
traveineuse Ic rapport de Ia clearance de l'urate a celle de Ia
créatinine exogène (Cr/Ccr) passe de 0,41 a 1,0 en dix minutes.
Cet effet persiste pendant encore 20 mm puis decline progressive-
ment pour atteindre une valeur de 0,70 a 100 mm. L'etl'et est le
même que l'animal soit ou non chargé en urate. Aucun effet
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uricosurique n'a été observe chez Ic chien dalmatien. Chez cet
animal Ic rapport Cur/Cc, baisse de 1,15 1,0 aprés l'ad-
ministration d'acide tiénilique. L'acide pyrazinoique adminis-
tré par voie intraveineuse a des chiens batards, charges en urate,
avant ou aprCs l'acide tiénilique n'influence pas Ia rCponse uricosu-
rique. Des etudes de diurèse interrompue montrent que I'acide
tiénilique bloque Ia reabsorption nette de l'urate dans le segment
proximal du néphron. II est aussi dCmontré que l'acide tiénilique
deprime de facon importante le transport du PAH aussi bien aux
fortes (20 mg/l00 ml) qu'aux faibles (I mg/l00 ml) concentrations
plasmatiques. Ainsi, Ia clearance du PAH ne peut pas être utilisée
pour mesurer Ic debit plasmatique renal si l'acide tiCnilique a etC
administrC, a moms que l'extraction rénale du PAH ne soit eva-
luée. Nous avons montrC que l'acide tiCnilique est aussi uricosu-
rique chez Ic rat, bien qu'â un degré moindre que chez Ic chien.
Malgré un effet natriurétique considerable l'acide tiénilique a une
action anti-uricosurique significative chez les animaux qui secre-
tent l'urate, tels le cobaye, Ic lapin et Ic poulet. Ce travail montre
que I'acide tiCnilique peut modifier de facon importante soit le flux
de reabsorption soit celui de secretion de I'urate. Cette action a lieu
dans le tube proximal et parait Ctre indCpendante de I'activité
natriurétique du compose. II est probable que Ia drogue entre en
competition dans Ia vole commune des acides organiques (PAH) et
que le transporteur commun a beaucoup plus d'affinité pour l'acide
tiénilique que pour Ic PAH.
Tienilic acid (2, 3-dichloro-4-[2-thienylcarbonylj
phenoxyacetic acid) is a new diuretic with a chemical
structure (Fig. I) resembling that of ethacrynic acid
[I]. This heterocyclic derivative of phenoxyacetic acid
was recently synthetized in France [I]. its natriuretic
effect is believed to take place in the cortical diluting
segment of the distal nephron [2, 3]. In contrast to all
other diuretics, perhaps with the exception of the
organo-mercurials [4], tienilic acid has been shown to
exert a significant and prolonged uricosuric effect in
man [5, 6]. Such an effect has also been reported in
the mouse by the team responsible for its synthesis
[I]. The nature and site of the uricosuric effect of
tienilic acid has not been established, One study in
man suggested that tienilic acid inhibits urate reab-
sorption distal to the site of urate secretion [7], while
another suggested inhibition of reabsorption at a pre-
secretory site in the nephron [3]. The present study
was undertaken in the mongrel dog, the Dalmatian
coachhound, the rat, the guinea pig, the rabbit, and
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Fig. I. Chemical structure of tienilic acid (2, 3-dichloro-4-12-
thienylcarbonylJ phenoxyacetic acid).
the chicken to clarify the nature of tienilic acid-in-
duced uricosuria.
Methods
Studies in dog. Fifty-nine experiments were per-
formed on 59 mongrel dogs and 18 experiments on 9
pedigreed Dalmatian coachhounds. All dogs were
female, weighing between 15 and 34 kg. The animals
were anesthetized with sodium pentobarbital (30
mg/kg) and intubated. The endotracheal tube was
connected to a volume and rate-adjustable respira-
tion pump (Harvard Apparatus Co., Inc., Millis,
MA) to maintain plasma carbon dioxide tension
(Pco2) around 40 mm Hg. Heparinized blood sam-
ples were drawn from the femoral artery. All solu-
tions were delivered to a femoral vein with a Bow-
man-type infusion pump at the rate of 5.0 mI/mm.
Adequate and stable urine flow was achieved by in-
fusing an isotonic solution containing half 5% manni-
tol and half 0.9% sodium chloride. Tienilic acid (SKF
62698) was administered i.v. as a single bolus diluted
in 5% glucose over a 5-mm period at a dosage of 50
mg/kg to 39 mongrel and 9 Dalmatian dogs. This
dosage was chosen because preliminary experiments
using a lower dosage (of 5 to 50 mg/kg) showed that
50 mg/kg induced the optimal effect on urate excre-
tion. All clearance periods were of 10-mm duration,
and samples from 10 periods were collected after the
administration of the drug. Five mongrel dogs re-
ceived tienilic acid in the absence of urate-loading. In
ten animals, urate-loading was achieved by adding to
the infusion uric acid neutralized to pH 7.40 with
sodium hydroxide. In five dogs, the effect of tienitic
acid was studied during continuous para-amino-
hippurate-loading (plasma PAH, 20 mg/l00 ml) and
simultaneous urate-loading. In these five experi-
ments, a catheter was introduced in the renal vein by
a technique already reported [81 to study the effect of
tienilic acid on renal extraction of PAH. This was
also done in five urate-loaded mongrel dogs to study
the renal extraction of PA H at low plasma concentra-
tion (I mg/l00 ml). In nine animals, pyrazinoic acid
(lot 5227 A, ICN Pharmaceuticals Inc., Plainview,
NY) was administered iv. as a prime (30 mg/kg),
followed by a sustained infusion (0.6 mg/kg/mm)
before or after the administration of tienilic acid.
Six mongrel dogs not loaded with urate were used
as controls and were given an i,v. single bolus of
furosemide (Lasix) (5 mg/kg) over a 5-mm period.
Also, ethacrynic acid (Edecrin) (2 mg/kg) was ad-
ministered to another group of five animals loaded
with urate.
The experimental protocol used in mongrel dogs to
study the effect of tienilic acid on urate excretion was
also used in five urate-loaded and four unloaded
pedigreed Dalmatian coachhounds.
Endogenous plasma urate averaged 0.3 mg/lOO ml
in nonloaded mongrel dogs, while plasma urate aver-
aged 3.0 mg/l00 ml in the urate-loaded animals. In
the unloaded Dalmatian coachhounds, plasma urate
averaged 0.7 mg/l00 ml and 2.4 mg/lOO ml in urate-
loaded dogs.
In all experiments, exogenous creatinine clearance
was taken as the measure of glomerular filtration
rate. Standard PAH clearance was used to measure
renal plasma flow during control periods, but could
not be used to measure changes in renal plasma flow
after the administration of tienilic acid since this drug
has a marked depressing effect on the renal extraction
of PAH (see Results). PAH clearance corrected for
renal extraction was measured in ten experiments.
In order to ascertain that an isotonic solution con-
taining half 5% mannitol and half 0.9% sodium chlo-
ride has no significant effect on urate excretion, this
solution was infused alone at 5 mI/mm continuously
during 120 mm to nine mongrel (five urate-loaded
and four unloaded) and nine Dalmatian (five urate-
loaded and four unloaded) (previously used) dogs.
Five stop-flow experiments using the left kidney
were performed on five urate-loaded mongrel dogs
before and after the administration of tienilic acid,
according to a procedure already reported from this
laboratory [9]. Inulin-methoxy-3H (New England
Nuclear, Boston, MA) (160 tCi) was used as the
glomerular marker. Five minutes before the release of
the ureteral clamp, 200 mg of PAH was injected.
Clamping time was 6 mm. Sixty serial urine samples
of approximately 0.5 ml were collected on each occa-
sion.
Siudies in rat. Eleven experiments were performed
in II female Sprague-Dawley rats weighing between
500 and 600 g. Following pentobarbital anesthesia
i.p. (4 mg/I00 g), the left jugular vein was catheter-
ized for the infusion of 0.06 mI/mm of the isotonic
mixture of half 5% mannitol and half 0.9% sodium
chloride, and containing adequate amounts of 14C-
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inulin for the measurement of glomerular filtration
rate. The right carotid artery was also catheterized to
obtain blood samples. The animals were then placed
in a temperature controlled cabinet (38°C) and con-
nected to a volume and rate adjustable respirator
(Harvard Apparatus Co., Millis, MA) following
cannulation of the trachea. Plasma Pco2 was main-
tained around 40 mm Hg. The abdominal cavity was
opened and a catheter (PE-lO) inserted in each ureter.
The whole surgical procedure took less than 50 mm.
Tienilic acid (50 mg/kg) was administered i.v, after
two 10-mm control clearance periods, and six 10-mm
urine collections were obtained following drug ad-
ministration. Five rats were urate-loaded (plasma
urate, 3.2 mg/lOO ml), and six animals were not
loaded (plasma urate 0.8 mg/l00 ml).
Studies in guinea pig. Six experiments were per-
formed on six female guinea pigs weighing between
600 and 900 g. The animals were not loaded with
urate. The same protocol was used as in the rat,
except for the rate of administration of the isotonic
mannitol-saline mixture which was administered at
0.10 mI/mm.
Studies in rabbit. Fourteen experiments were per-
formed on 14 New Zealand, white, male rabbits
weighing between 1.6 and 4.2 kg. Light anesthesia
was induced by sodium pentobarbital (15 mg/kg)
administered through the marginal vein of the
ear. Adequate body temperature was maintained
throughout each experiment with a heating lamp.
Blood samples were obtained from the carotid artery,
and all solutions were delivered to a jugular vein with
a Bowman-type infusion pump at the rate of 2.7
mI/mm. Exogenous creatinine clearance was used to
measure glomerular filtration rate. Like in the dog,
standard PAH clearance could not be used to mea-
sure renal plasma flow variations. Six animals re-
ceived 5% mannitol alone, while eight animals were
studied during urate-loading with a mean plasma
concentration of 7.5 0.90 mg/100 ml. In nonloaded
animals, plasma urate averaged 0.3 0.02 mg/l00
ml. Tienilic acid was given as a slow single injection
of 5-mm duration at a dosage of 50 mg/kg. Five 10-
mm clearance periods were obtained after the injec-
tion of tienilic acid.
Studies in chicken. Six experiments were performed
on six laying, white, leghorn hens weighing between
1.7 and 2.7 kg. Endogenous plasma urate ranged
from 5.7 to 43.9 mg/lOO ml (mean, 25.1 6.7
mg/lOO ml). The unanesthetized birds were re-
strained with outspread wings. In all experiments,
glomerular filtration rate was measured by inulin
clearance using 14C-inulin. The animals were infused
with 5% mannitol at 2.0 mI/mm in the wing vein.
Tienilic acid was given i.v. as a single bolus of 50
mg/kg over 5 mm. Urate excretion was followed at
10-mm intervals during 50 mm following tienilic acid
administration. Heparinized blood samples were
taken from a polyethylene cannula inserted in the
wing artery. Each ureter was catheterized after the
onset of diuresis and fluidization of urine. The cath-
eters were tied to the cloacal mucosa to avoid any
leaks, as previously described [111.
Analytical methods. Uric acid in plasma and urine
was measured on the Auto-Analyzer by the method
of Brown [101. The validity of this method for mea-
surement of urate in plasma and urine in dog, rat,
guinea pig, rabbit, and chicken has been previously
established in our laboratory [11]. This method in-
troduces only a slight (7%) error in the measurement
of urate in the plasma of rabbits [11]. It was ascer-
tained that tienilic acid does not influence the mea-
surement of uric acid by this method. Para-amino-
hippurate clearance was determined by the method of
Bratton and Marshall, as modified by Smith et al
[12]. The method of Bonsnes and Taussky [13] was
used to measure creatinine. '4C-inulin, inulin-me-
thoxy-3H, and urate-2-'4C concentrations were
counted with a liquid scintillation spectrometer
(Searle-Nuclear-Chicago, model Isocap-300), as pre-
viously described [9]. No significant difference in
quenching was noted between samples. Sodium and
potassium in plasma and urine were measured by
flame photometry. Blood pH and Pco2 were mea-
sured with appropriate electrodes [11]. Statistical
analysis was performed using the conventional Stu-
dent's t test for paired data, Results are reported in
the text as means SEM. Throughout the text, the
term "significant" is used to describe a difference
which has a P value of less than 0.05.
Results
Studies in dog. As shown in Figure 2, the adminis-
tration of tienilic acid to mongrel dogs without urate-
loading led to a marked increment in uric acid excre-
tion, the ratio of urate over exogenous creatinine
clearance (Cur/Ccr) rising from 0.41 0.06 to a
value near unity (P < 0.01) within 10 mm after the
administration of the drug. This effect persisted for
another 20 mm and declined progressively thereafter
to a value of 0.70 0.09 at 100 mm. In these experi-
ments, exogenous creatinine clearance did not de-
crease by more than 20%, while urate clearance in-
creased 2.5-fold at the peak of the uricosuric effect. In
the 10 urate-loaded mongrel dogs the results were
similar, Cur/Ccr increasing from 0.64 0.03 to 1.00
0.05 (P < 0.01) (Fig. 2). This high value was
unchanged throughout the 100 mm during which the
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Fig. 2. Uricosuric effect of tienilic acid in unloaded and urate-loaded
mongrel dogs.
clearance periods were obtained. In these experi-
ments, creatinine clearance did not change, while
urate clearance increased markedly. A representative
experiment in a urate-loaded mongrel dog is shown in
Table 1. In contrast to tienilic acid, furosemide ad-
ministered to dogs without urate-loading or ethacry-
nic acid given to urate-loaded animals had no effect
whatsoever on urate excretion (Fig. 2 and Table 2).
Sodium and potassium excretion during the adminis-
tration of each diuretic is shown in Table 2. It is
evident that comparable natriuresis and kaliuresis
were achieved with each drug. The fractional excre-
tion of sodium (FENa) was greater with furosemide
and ethacrynic acid because these agents had a
greater depressing effect on glomerular filtration rate
than tienilic acid. In spite of similar electrolyte excre-
tion, it is evident that only tienilic acid had a marked
and continued effect on urate excretion. The lack of
effect of either furosemide or ethacrynic acid on urate
excretion is independent of plasma urate concentra-
tion since the animals receiving ethacrynic acid were
urate-loaded, while those receiving furosemide were
not.
A marked fall in PAH clearance was noted in all
the experiments with tienilic acid. This is due to the
fact that tienilic acid has a spectacular effect on the
renal extraction of PAH. A detailed study performed
at low and high plasma PAH concentrations is shown
in Table 3. Standard PAH clearance fell by 56% (P <
0.01) one hour after the administration of tienilic acid
at low plasma PAH concentration and the PAH
clearance approached glomerular filtration rate. The
60% fall in PAH extraction (P < 0.01) fully explains
the observed fall in PAH clearance. When corrected
for renal extraction, PAH clearance showed no sig-
nificant variation over control for at least 100 mm
after the administration of tienilic acid. At high
plasma PAH concentration sufficient to saturate the
tubular secretion process, tienilic acid had the same
depressing effect on PAH clearance (P < 0.02), while
the latter showed no change whatsoever when cor-
rected for renal extraction. Maximal tubular secre-
Table 1. Effect of tienilic acid on urate excretion during PA H-loading in a urate-loaded mongrel dog
Plasma Plasma PAH
Time PAH urate V Cçr Cur CPAH TPAH extraction CPAHO
rn/n mg/IOU ml mg/IOU ml mi/mm mi/mm mi/mm Cur/Ccr mi/mm mg/rn/n % mi/mm
Prime; 900 rng of creatinine and 2 g of PA H
—75
Infusion: creatinine. 0.2 mg/kg/mm; PAH, 1.0 mg/kg/rn/n; uric acid; 0.3 mg/kg/mm; in half 5% mannitol and half 0.9%
sodium chloride at 5 mi/mm
—3Oto —20 31.3 2.6 1.1 65.6 36.3 0.55 98.3 10.24 42.8 229.5
—2Oto —10 31.3 3.2 1.2 68.5 37.7 0.55 100.8 10.11 38.0 265.3
—lOto 0 29.9 3.3 1.3 71.9 39.6 0.55 97.0 7.50 41.6 233.2
0 to 5 Tieniic acid, 50mg/kg i.v.
Sto 15 30.0 3.8 4.4 55.8 60.1 1.08 54.9 —0.27 25.4 216.1
15 to 25 31.9 3.9 5.5 62.9 68.7 1.09 63.6 +0.22 30.6 207.8
25 to 35 33.0 4.0 4.8 58.1 62.3 1.07 52.7 —1.78 34.6 152.3
35 to 45 30.9 3.8 4.7 59.8 65.6 1.10 65.0 + 1.61 30.2 215.2
4Sto 55 31.3 3.8 4.4 57.2 61.4 1.07 62.9 +1.78 29.2 215.4
55 to 65 31.3 3.7 3.7 60.8 60.0 0.99 67.7 +2.16 31.2 217.0
6Sto 75 31.1 3.8 3.5 56.7 57.8 1.02 62.5 +1.80 30.9 202.3
75 to 85 31.3 4.0 3.0 53.9 51.5 0.96 51.2 —0.85 31.5 162.5
85 to 95 32.3 3.9 3.1 55.1 54.9 1.00 51.5 —1.16 35.0 147.1
95to 105 31.3 3.9 3.0 55.1 54.9 1.00 53.0 —0.66 36.2 146.4
Female mongrel dog no. 101, 19.0 kg, May 18, 1976.
= PAH clearance corrected for renal extraction. Other abbreviations used are: C = clearance, Cr = creatinine, Ur = urate,
TPAH = transport maximum for PAH, V = urine flow.
o SKF 62698, 50 mg/kg, no urate-loading (N = 5)
• SKF 62698, 50 mg/kg, urate-loading (N = 10)
A Furosemide, 5 mg/kg, no urate—loading (N = 6)
• Ethacrynic acid, 2 mg/kg, urate-loading (N = 5)
Drug1.5-
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tion of PAH was depressed by 80% (P < 0.01)(Table
3). Thus, standard PAH clearance cannot be used to
measure variations in renal plasma flow following
tienilic acid, unless it is corrected for renal extraction.
In the five urate-loaded and four unloaded Dalma-
tian coachhounds, the ratio of Cur/Ccr was slightly
above unity (1.15 0.07) prior to tienilic acid admin-
istration. This value fell to unity (P < 0.01) following
the administration of tienilic acid and remained at or
near unity (Fig. 3). In these experiments, exogenous
creatinine clearance did not decrease by more than
15%, but PAH clearance fell by 40% for the reason
mentioned previously. In these animals, the natri-
uretic effect of tienilic acid was similar to that noted
in the mongrel dogs.
In the nine mongrel dogs and the nine Dalmatian
coachhounds, either loaded or unloaded with urate
which received the isotonic mannitol-saline mixture
continuously during 120 mm in the absence of admin-
istration of any drug, Cur/Ccr remained unchanged,
as well as PAH excretion.
The effect of pyrazinoic acid on the uricosuric ef-
fect of tienilic acid in urate-loaded mongrel dogs is
shown in Table 4. In the first series of experiments,
pyrazinoic acid was administered prior to and contin-
ued after tienilic acid administration. Despite urate-
loading, it had only a moderate but significant effect
on urate excretion, Cr/Cc falling from 0.72 to 0.61,
a mean fall of 15% (P < 0.01). The uricosuric effect of
tienilic acid was not markedly altered by pyrazinoic
acid since Cur/Ccr rose significantly from 0.61 to 0.89
within 20 mm (P < 0.01). When tienilic acid was
administered prior to pyrazinoic acid, the latter also
had no significant effect on Cur/C0r (Table 4).
The results of the stop-flow studies performed in
five urate-loaded mongrel dogs are shown in Table 5
and Figure 4, the latter showing a representative ex-
periment. During the control period, maximal reab-
sorption of urate was noted in the proximal segment,
together with maximal secretion of PAH. Following
the administration of tienilic acid, the ratio of urine
to plasma (U/P) urate over U/P creatinine rose from
0.41 to 0.75 in the proximal segment (P < 0.01) and
from 0.62 to 0.90 (P < 0.01) in the distal segment, the
latter value being similar to that found during free-
flow before and after ureteral occlusion. At the same
time, proximal secretion of PAH was markedly inhib-
ited, the ratio of U/PpAH/U/PCr falling from 5.59 to
1.78 (P < 0.01), while a value near unity was ob-
served at the distal site and during free-flow condi-
tions.
Studies in rat. The results of the 11 experiments
performed in five urate-loaded (plasma urate, 3.2
0.50 mg/l00 ml) and six unloaded (plasma urate, 0.8
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Table 3. Effect of tienilic acid on renal hemodynamics and para-aminohippurate (PAH) extraction in the dog5
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Low plasma PAH (N = 5) High plasma PAH (N = 5)
Time GFR PPAH CPAU EPAK GFR PPAH CPAU EPAH CPAH, T5
mm mi/mm mg/lOOm! mi/mm % mi/mm mi/mm mg/100m1 mi/win % mi/mm mg/mm
—10 to —20 60+ 8.5 0.79±0.1 139±28.0 81 1.9 168±33 69+ 1.1 20±4.2 117±6.4 55 213 +20 8.8+0.8
Tienilic acid. 50 mg/kg
50 to 60 50 + 5.7 1.4 + 0.2 61 8.7 33 3.8 197 29 67 3.6 24 + 2.8 73 + 7.6 30 + 3.4 252 + 40 1.8 + 1.8
90 to 100 51 4.6 1.5 0.2 80 + 10.0 48 + 3.6 163 + II 64 + 3.4 25 2.2 75 6.8 30 + 2.7 259 + 42 2.5 0.9
120 to 130 45 5.0 1.6 0.3 77 9.6 59 + 2.8 128 + 10 59 + 3.4 26 + 2.3 69 8.0 32 + 2.7 220 + 36 1.6 1.2
Values are means + SEM.
Abbreviations used are: EFAH = renal extraction of PAH, CPAH, = PAH clearance corrected for renal extraction, GFR = glomerular
filtration rate, P = plasma, C clearance, TPAH = transport maximum for PAH.
0.14 mg/100 ml) rats are presented in Figure 5. In
the loaded animals, Cr/Cin rose from 0.75 0.09 to
1.00 0.04 (P < 0.05) within 10 mm after the admin-
istration of tienilic acid. This effect continued for the
next 20 mm, falling off to 0.86 0.07 after one hour.
In the unloaded animals, Cr/Cin rose from 0.21
0,04 to 0.46 0.08 (P < 0.01) within 10 mm and to
0.54 0.09 (P < 0.01) after 30 mm, decreasing to
0.43 0.07 after 60 mm. Thus, the increment in
Cur/Cm following tienilic acid was the same in both
groups of animals. Maximal natriuresis was observed
20 mm after the administration of the drug, the frac-
tional excretion of sodium rising from 2.7 0.64% to
4.7 + 0.42% (P < 0.01) in the unloaded animals and
from 4.7 1.18% to 9.5 1.41% (P < 0.02) in the
urate-loaded ones. A moderate kaliuretic effect ac-
companied the increase in sodium excretion.
Studies in guinea pig. Figure 6 shows the results
of the six experiments performed on guinea pigs
not loaded with urate. During the control period,
Cur/Cm averaged 1.32 0.20, indicating net secre-
tion. Endogenous plasma urate averaged 0.6 0.14
mg/I00 ml. Following the administration of tienilic
acid, Cur/Cm fell markedly from 1.32 to 0.22 0.04
(P < 0.01), indicating abolition of net secretion and
unmasking important net reabsorption. Plasma urate
rose from 0.60 0.14 to 0.74 0.22 mg/l00 ml (P <
0.05), a significant increase attributable to urate re-
tention. This marked inhibitory effect on urate excre-
tion occurred in spite of a significant natriuresis, the
fractional excretion of sodium increasing from 1.4
3
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Fig. 3. EJj'ct of tienilic acid on urate excretion in urate-ioaded and
nonloaded Dalmatian coachhounds.
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Fig. 4. Effect of tien/lie acid (dark symbols) on urate and PA H
transport in a urate-loaded mongrel dog (VA = uric acid).
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Table 4. Effect of pyrazinoic acid (PZA) on uricosuric effect of trenilic acid in urate-loaded mongrel dogsa
0.65 to 6.0 2.70% (P< 0.05). Glomerular filtration
rate remained stable throughout each experiment.
Studies in rabbit. Tienilic acid showed no uricosuric
properties in either urate-loaded or unloaded rabbits.
Cr/Ccr in the unloaded animals averaged 0.79
0.10, whereas this value was 1.50 0.10 in the loaded
ones, indicating net secretion (Fig. 7). Following ii-
enilic acid administration, Cur/Car fell by 32% (P <
0.01) in unloaded animals and 41% (P < 0.01) in the
urate-loaded rabbits. In the latter animals, the fall of
Cr/Ccr from 1.50 to 0.88—1.10 indicates suppression
of net secretion of urate (Fig. 7). PAH clearance fell
by 41% (P <0.01) in the unloaded and by 56% (P <
0.01) in the urate-loaded rabbits, presumably for the
same reason as in the dog, but the renal extraction of
PAH was not measured in these experiments. Ten
minutes after the administration of tienilic acid, gb-
merular filtration rate had fallen by 19% and urate
clearance by 46% in the unloaded animals. The same
relationship was found in urate-loaded rabbits. The
natriuretic effect of tienilic acid was again observed,
FENa increasing from 5.3 1.32% to 21.5 1.47% (P
< 0.01) in unloaded and from 9.5 1.07% to 32.2
2,21% (P < 0.01) in urate-loaded animals.
Studies in chicken. Tienilic acid injected in a wing
vein induced a striking reduction in urate excretion
(Fig. 8). In these experiments, Cr/Cin fell from 8.1
+ 2.59 to 3.2 0.70 (P < 0.02). Inulin clearance
remained stable throughout each experiment at 1.4 +
0.40 mI/mm. Thus, net secretion of urate fell by 61%.
Table 5. Effect of tienilic acid on renal handling of urate during stop-flow in the dog (left kidney) (N =
Plasma Free-flow Distal Proximal Free-flow
Control:
GFR, mI/mm 26.2 3.6 26.0 3.5
U/P urate/U/Pcreatinine 0.644 + 0.019 0.617 0.015 0.412 0.030 0.635 0.030
U/P PAH/U/P creatinine 2.24 0.47 2.87 + 1.27 5.59 + 2.43 2.48 + 0.45
UNa, ,nEq/liter 64.7 9.60 12.6 + 1.82 74.6 + 15.0 56.9 + 11.8
P urate, mg/I0O ml 6.8 + 1.5
PPAH. mg/IOO ml 4.0 0.02
Tienilic acid, 50mg/kg:
GFR,mt/min 24.0 3.2 25.1 3.5
U/P urate/U/P creatinine 0.852 + 0.030 0.900 + 0.018 0.750 + 0.016 0.850 + 0.025
U/P PAH/U/Pcreatinine 1.08 0.06 1.9 + 0.27 1.78 0.66 1.20 0.38
UN,mEq/liter 81.5 + 8.93 18.6 3.5 73.4 11.6 77.5 + 8.6
Purate,mg/lOOml 8.8± 1.9
PPAH, mg/IOU ml 6.8 + 0.02
Values are means SEM.
See preceding tables for abbreviations used.
Time
N=4 N=5
Pur GFR Pur GFR
mm mg/tOO ml mi/mm Cut/Ccr mg/IOU ml mi/mm Cur/Ccr
—30 to —20
Control
3.2 0.3 73 5.5 0.72 + 0,02 3.1 + 0.2 57± 3 0.54 + 0.04
—20 to —10 3.3 + 0.3 74 6.8 0.69 0.06 3.2 + 0.1 57± 4 0.54 + 0.04
—10 to 0 3.4 + 0.4 71 + 4.0 0.74 + 0.04 3.3 0.2 55 4 0.54 0.07
10 to 20
PZA: prime, 30mg/kg; sustained infusion, 0.6 mg/kg/mm
3.7 + 0.6 65 + 5.6 0.73 0.03
Tienilic acid, 50 mg/kg
3.5 + 0.2 55 + 2 1.00 0.07
20 to 30 4.0 + 0.8 71 + 5.2 0.64 + 0.02 3.6 + 0.2 59 3 0.95 + 0.07
30 to 40 4.0 0.8 67 5.4 0.64 0.03 3.7 0.2 54 3 0.96 0.06
40 to 50 4.1 + 0.8 72 7.5 0.62 0.04 3.9 + 0.2 53 + 3 0.97 0.05
50 to 60 4.! + 0.9 81 + 5.7 0.6! + 0.01 3.9 0.3 52 4 0.94 0.06
60 to 70
Tienilic acid, 50mg/kg
3.8 0.6 62 + 3.8 0.84 + 0.05
PZA: prime, 30mg/kg; sustained infusion, 0.6 mg/kg/mm
3.8 0.3 56 5.7 0.94 0.04
70 to 80 4.4 + 0.8 76 2.1 0.89 0.07 3.9 64 4.0 0.88 0.06
80 to 90 4.4 + 0.9 75 + 3.2 0.83 0.04 3.7 + 0.6 52 + 3.2 0.93 + 0.08
90 to 100 4.4 + 1.0 74 3.6 0.85 0.07 3.7 0.6 57 + 6.1 0.89 0.06
100 to 110 4.3 1.0 77 5.4 0.84 0.07 3.8 + 0.6 50 + 3.1 0.89 + 0.06
110 to 120 4.4 1.1 64 + 8.5 0.80 0.07 4.0 0.4 54 3.1 0.90 0.06
Values are means + SEM. N = number of animals. Cr/Ccr = ratio of urate clearance to creatinine clearance. GFR = glomerular filtration
rate. Pur = plasma urate.
Uricosuric effect of tienilic acid
At the same time, plasma urate rose from 25.1 6.73
mg/100 ml to a maximal value of 38.8 8.68 mg/100
ml (P < 0.01) 30 mm after tienilic acid administration
and remained at 36.5 + 9.23 mg/lOO ml at 50 mm.
Thus, suppression of net urate secretion by tienilic
acid led to a rapid and important (55%) increase in
plasma urate. No PAH was administered to these
animals. FENa rose from 9.5 + 1.79% to 50.6 + 2.80%
(P < 0.01) following tienilic acid.
Discussion
At the dosage used in the present study, tienilic
acid is certainly the most important uricosuric agent
ever reported in the mongrel dog. The fact that fil-
tered urate excretion reached 100% following the ad-
ministration of this drug indicates complete inhibi-
tion of net urate transport in the nephron of the
mongrel dog. In view of the effect observed in the
mongrel dog, one did not expect tienilic acid to in-
crease urate excretion in the Dalmatian coachhound.
In fact, in Dalmatians with Cur/Ccr ratio slightly
above unity, this ratio fell rapidly toward unity fol-
lowing tienilic acid administration, indicating inhibi-
tion of the slight net urate secretion observed during
the control period. Thus, tienilic acid inhibits net
reabsorption of urate in the mongrel dog and net
secretion in the Dalmatian. Since bidirectional move-
ment of urate has been shown to take place in the
proximal nephron of the dog [14, 15], it is probable
that both reabsorptive and secretory fluxes are inhib-
ited by tienilic acid in the mongrel dog.
The magnitude of the uricosuric response observed
in mongrel dogs suggests that tienilic acid affects
urate transport mainly in the proximal tubule. This is
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Fig. 6. Effect of sienilic acid on urate excretion in guinea pigs.
supported by the fact that tienilic acid inhibits the
renal tubular transport of para-aminohippurate in
this species, even at high PAH plasma concentration.
More direct evidence of inhibition of both urate and
PAH transport at the proximal site was obtained by
our stop-flow studies. One must certainly envisage
that both tienilic acid and PAH compete for a com-
mon pathway for secretion in the proximal tubule, if
tienilic acid can be shown to be secreted. If so, the
lack of effect of PAH-Ioading on the uricosuric action
of tienilic acid would further suggest that the com-
mon carrier has a far greater affinity for tienilic acid
than for PAH.
The proximal uricosuric effect of tienilic acid in the
mongrel dog is most likely independent of the natri-
1.0
0.8
O.6
0.4
0.2
SKF 62698
50 mg/kg
N=6 U
SKF 62698
50 mg/kg
I I I I I I —
—10 0 10 20 30 40 50 60
Time, mm
Fig. 5. Effect of tienilic acid on urate excretion in urate-loaded
(upper line) and unloaded (lower line) rats.
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Fig. 7. Effect of tienilic acid on urate excretion in urate-loaded and
unloaded rabbits.
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Effect of tienilic acid on urate excretion and plasma urate in
uretic effect of the drug which apparently takes place
in man in the cortical diluting segment of the distal
tubule [2, 3]. This point is well illustrated by our
control study with furosemide and ethacrynic acid,
both loop diuretics [16] which have no effect on urate
excretion in the dog despite a comparable or greater
natriuretic effect than tienilic acid at the dosage used.
Although we are certain that in the dog tienilic acid
exerts its uricosuric effect in the proximal segment of
the nephron, we cannot exclude with certainty an
additional effect on urate transport in the ioop of
Henle and at a more distal site. According to recent
micropuncture and microperfusion studies in the rat,
the importance of urate transport in the 1oop of
Henle [17—20] and the distal tubule [20—22] has be-
come a matter of controversy. Studies in mongrel
dogs show, however, that urate transport occurs only
in the proximal convoluted tubule in this species [15,
23], while urate secretion in the Dalmatian coach-
hound does not extend beyond the straight segment
of the proximal tubule [23]. We therefore feel that, at
least in the dog, tienilic acid is unlikely to exert any
effect on urate transport beyond the proximal tubule.
The i.v. administration of pyrazinoic acid (PZA), a
well known inhibitor of urate secretion in man [24,
25], had only a slight depressing effect on urate excre-
tion in the mongrel dog. Such a slight effect has
already been observed by Yu, Berger, and Gutman
[26]. Tienilic acid exerted its usual pronounced
uricosuric effect whether pyrazinoic acid was admin-
istered before or after tienilic acid. Thus, in the
mongrel dog, the uricosuric effect of tienilic acid is
not PZA suppressible.
The control studies demonstrate that in either the
mongrel or the Dalmatian coachhound, the contin-
ued and prolonged administration of the isotonic
mannitol-saline mixture used in this study had no
effect whatsoever on urate or PAH excretion, Thus,
any effect of tienilic acid on urate and PAH observed
in this species can only be attributed to the drug itself.
We have demonstrated that tienilic acid is also
uricosuric in the rat. This effect is less pronounced
than in the mongrel dog. Our results are in agreement
with those reported in mice by Thuillier et al [I].
Thus, it is of interest to note that tienilic acid has a
uricosuric effect in man [5, 6], mongrel dog, rat and
mouse [I], all species where urate reabsorption is
preponderant.
Our study in the rabbit, guinea pig, and chicken
adds useful information concerning the mode of ac-
tion of tienilic acid on urate excretion. Net secretion
of urate is readily demonstrable in guinea pigs [27]
and in rabbits loaded with urate [28]. The fact that
tienilic acid completely abolished net secretion of
urate in guinea pigs and urate-loaded rabbits, while
inducing significant reduction in urate excretion in
nonloaded rabbits, suggests that in these species, tie-
nilic acid inhibits urate secretion and has no demon-
strable net effect on urate reabsorption. This could
also be taken to indicate that in the rabbit and guinea
pig, the secretory flux is more important than in the
mongrel dog and even in the Dalmatian coachhound.
The present observations in the chicken leave no
doubt about the ability of tienilic acid to depress
urate secretion in this animal. This inhibitory effect is
remarkable in view of the fact that pyrazinamide, a
potent inhibitor of urate secretion in man [24], Cebus
monkey [29], and Dalmatian coachhound [26] has no
effect on urate excretion in the chicken [30]. The
striking inhibitory effect of tienilic acid on urate ex-
cretion in the chicken is reminiscent of that reported
in this animal for salicylate, and especially probe-
necid at high dosage [30]. The rapid and striking rise
in plasma urate concentration when tienilic acid is
administered to the chicken is highly confirmatory of
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the ability of the drug to induce marked suppression
of urate secretion.
The spectacular drop in urate secretion observed in
guinea pig, rabbit, and chicken adds support to our
suggestion that tienilic acid can inhibit either the net
reabsorptive or secretory flux depending on the mag-
nitude of each flux in a given animal species. Thus, it
has a uricosuric effect in the mongrel dog and the rat
where the secretory flux is probably slight and has an
inhibitory effect in animals like the Dalmatian coach-
hound, guinea pig, rabbit, and chicken, in which the
secretory flux of urate is predominant.
Little is presently known of the metabolism of
tienilic acid in the animal species used in the present
study. The drug is highly bound to plasma protein in
mouse, rat, pig, and dog [31]. It is unlikely, however,
that the uricosuric effect of tienilic acid in the mon-
grel dog, rat, mouse, and even man could be ex-
plained by an effect of the drug on the binding of
urate to plasma protein, a mechanism suggested by
Campion, Bluestone, and Klinenberg for other urico-
suric agents [32, 33]. Many believe that little urate is
bound to plasma proteins at 37°C [34—37]. Simkin
could not demonstrate protein-binding of urate in
mongrel dogs [38]. Furthermore, such a mechanism
could not explain the antiuricosuric effect of tienilic
acid in the guinea pig, rabbit, and chicken. It is more
likely that the action of tienilic acid on urate trans-
port is related to its secretion and/or reabsorption in
the renal tubule. This is suggested by the rapid elimi-
nation of the drug in urine (and bile) in mouse, rat,
pig, and dog [31].
It is evident from the present study that tienilic acid
has little effect on renal hemodynamics, if it is real-
ized that PAH clearance cannot be used to measure
renal plasma flow following its administration, unless
the renal extraction of PAH is also determined.
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